Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
64.97M | 78.19M | 95.91M | 120.55M | 91.10M | Gross Profit |
41.86M | 51.58M | 63.52M | 74.22M | 65.26M | EBIT |
-14.76M | -3.83M | 3.76M | 17.31M | 11.55M | EBITDA |
-4.89M | 1.79M | 19.07M | 32.73M | 17.92M | Net Income Common Stockholders |
-17.27M | -11.05M | 5.23M | 14.56M | 5.22M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
12.19M | 9.48M | 22.18M | 29.14M | 16.77M | Total Assets |
106.81M | 99.79M | 114.97M | 138.27M | 129.13M | Total Debt |
32.82M | 19.34M | 20.94M | 22.56M | 25.91M | Net Debt |
20.63M | 9.86M | -1.25M | -6.58M | 9.14M | Total Liabilities |
71.54M | 48.11M | 52.29M | 67.88M | 73.58M | Stockholders Equity |
35.27M | 51.68M | 62.68M | 70.39M | 55.55M |
Cash Flow | Free Cash Flow | |||
-922.00K | -2.02M | 26.21M | 34.77M | 1.65M | Operating Cash Flow |
78.00K | -1.50M | 26.77M | 35.22M | 2.48M | Investing Cash Flow |
-1.27M | -522.00K | -7.61M | -12.78M | -4.33M | Financing Cash Flow |
3.98M | -10.73M | -25.82M | -10.12M | -4.17M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | HK$140.00M | 13.89 | 7.02% | 9.60% | -17.13% | -51.35% | |
61 Neutral | $6.98B | 11.35 | 2.88% | 3.90% | 2.65% | -21.84% | |
51 Neutral | HK$84.75M | ― | -5.25% | ― | -25.44% | 41.67% | |
50 Neutral | HK$199.49M | 516.95 | 0.83% | ― | 4.23% | -40.55% | |
47 Neutral | HK$18.35M | ― | -2.91% | ― | 10.22% | 92.89% | |
36 Underperform | HK$364.32M | ― | -16.42% | ― | -13.93% | 75.32% |